Correction: GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma

Muranushi, Hiroyuki; Shindo, Takero; Hishizawa, Masakatsu; Tokunaga, Masahito; Wake, Atsushi; Nakano, Nobuaki; Eto, Tetsuya; Hidaka, Michihiro; Choi, Ilseung; Miyamoto, Toshihiro; Uchida, Naoyuki; Moriuchi, Yukiyoshi; Miyazaki, Yasuhiko; Fukuda, Takahiro; Ichinohe, Tatsuo; Atsuta, Yoshiko; Kato, Koji

doi:10.1038/s41409-020-01037-4

Correction: GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma

Correction
Published: 25 August 2020

Volume 56, page 298, (2021)
Cite this article

Download PDF

Bone Marrow Transplantation Submit manuscript

Correction: GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma

Download PDF

Hiroyuki Muranushi¹,
Takero Shindo ORCID: orcid.org/0000-0002-2085-6151¹,
Masakatsu Hishizawa¹,
Masahito Tokunaga²,
Atsushi Wake³,
Nobuaki Nakano²,
Tetsuya Eto⁴,
Michihiro Hidaka⁵,
Ilseung Choi⁶,
Toshihiro Miyamoto⁷,
Naoyuki Uchida⁸,
Yukiyoshi Moriuchi⁹,
Yasuhiko Miyazaki¹⁰,
Takahiro Fukuda¹¹,
Tatsuo Ichinohe¹²,
Yoshiko Atsuta^13,14,
The ATL Working Group of the Japanese Society for Hematopoietic Cell Transplantation &
…
Koji Kato⁷

The Original Article was published on 14 July 2020

Correction to: Bone Marrow Transplantation

https://doi.org/10.1038/s41409-020-00996-y

In the original version of this article, the legends to Figs. 1 and 2 were incorrect. This has now been corrected in the PDF and HTML versions of the article.

Author information

Authors and Affiliations

Department of Hematology/Oncology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Hiroyuki Muranushi, Takero Shindo, Masakatsu Hishizawa, Tomoki Iemura, Takuya Shimizu & Mari Morita-Fujita
Department of Hematology, Imamura General Hospital, Kagoshima, Japan
Masahito Tokunaga, Nobuaki Nakano & Atae Utsunomiya
Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan
Atsushi Wake
Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan
Tetsuya Eto
Department of Hematology, Kumamoto Medical Center, Kumamoto, Japan
Michihiro Hidaka
Department of Hematology, National Kyushu Cancer Center, Fukuoka, Japan
Ilseung Choi
Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan
Toshihiro Miyamoto, Koji Kato, Koji Kato & Koji Kato
Department of Hematology, Toranomon Hospital, Tokyo, Japan
Naoyuki Uchida
Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
Yukiyoshi Moriuchi
Department of Hematology, Oita Prefectural Hospital, Oita, Japan
Yasuhiko Miyazaki
Department of Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
Takahiro Fukuda
Research Institute for Radiation Biology and Medicine, Department of Hematology and Oncology, Hiroshima University, Hiroshima, Japan
Tatsuo Ichinohe
Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
Yoshiko Atsuta
Nagoya University Graduate School of Medicine, Nagoya, Japan
Yoshiko Atsuta
Department of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan
Makoto Yoshimitsu
Department of Internal Medicine, Division of Hematology and Oncology, Iwate Medical University School of Medicine, Morioka, Japan
Takashi Ishida
Innovative Cancer Center/Oncology-Hematology, Shimane University Hospital, Izumo, Japan
Junji Suzumiya
Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan
Tomomi Tobai
Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Japan
Koichi Nakase & Yuichiro Nawa
Division of Endocrinology, Diabetes and Metabolism, Hematology and Rheumatology, Second Department of Internal Medicine, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan
Takuya Fukushima & Satoko Morishima
Department of Hematology, Okinawa Red Cross Hospital, Naha, Japan
Yoshitaka Asakura
Department of Immuno-gene therapy, Center for Comprehensive Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu, Japan
Hiroshi Fujiwara
Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan
Shinichiro Machida
Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan
Yasushi Sawayama
Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan
Yoshitaka Inoue
Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan
Kazunori Imada
Department of Hematologic Oncology, Shikoku Cancer Center, Matsuyama, Japan
Isao Yoshida
Department of Hematology, Osaka International Cancer Center, Osaka, Japan
Shigeo Fuji
Department of Hematology and Oncology, Nakagami Hospital, Okinawa, Japan
Shohei Tomori

Authors

Hiroyuki Muranushi
View author publications
You can also search for this author in PubMed Google Scholar
Takero Shindo
View author publications
You can also search for this author in PubMed Google Scholar
Masakatsu Hishizawa
View author publications
You can also search for this author in PubMed Google Scholar
Masahito Tokunaga
View author publications
You can also search for this author in PubMed Google Scholar
Atsushi Wake
View author publications
You can also search for this author in PubMed Google Scholar
Nobuaki Nakano
View author publications
You can also search for this author in PubMed Google Scholar
Tetsuya Eto
View author publications
You can also search for this author in PubMed Google Scholar
Michihiro Hidaka
View author publications
You can also search for this author in PubMed Google Scholar
Ilseung Choi
View author publications
You can also search for this author in PubMed Google Scholar
Toshihiro Miyamoto
View author publications
You can also search for this author in PubMed Google Scholar
Naoyuki Uchida
View author publications
You can also search for this author in PubMed Google Scholar
Yukiyoshi Moriuchi
View author publications
You can also search for this author in PubMed Google Scholar
Yasuhiko Miyazaki
View author publications
You can also search for this author in PubMed Google Scholar
Takahiro Fukuda
View author publications
You can also search for this author in PubMed Google Scholar
Tatsuo Ichinohe
View author publications
You can also search for this author in PubMed Google Scholar
Yoshiko Atsuta
View author publications
You can also search for this author in PubMed Google Scholar
Koji Kato
View author publications
You can also search for this author in PubMed Google Scholar

Consortia

The ATL Working Group of the Japanese Society for Hematopoietic Cell Transplantation

Koji Kato
, Makoto Yoshimitsu
, Takashi Ishida
, Atae Utsunomiya
, Koji Kato
, Junji Suzumiya
, Tomomi Tobai
, Koichi Nakase
, Yuichiro Nawa
, Takuya Fukushima
, Yoshitaka Asakura
, Hiroshi Fujiwara
, Shinichiro Machida
, Yasushi Sawayama
, Yoshitaka Inoue
, Kazunori Imada
, Isao Yoshida
, Shigeo Fuji
, Satoko Morishima
, Shohei Tomori
, Tomoki Iemura
, Takuya Shimizu
& Mari Morita-Fujita

Corresponding author

Correspondence to Takero Shindo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muranushi, H., Shindo, T., Hishizawa, M. et al. Correction: GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma. Bone Marrow Transplant 56, 298 (2021). https://doi.org/10.1038/s41409-020-01037-4

Download citation

Published: 25 August 2020
Issue Date: January 2021
DOI: https://doi.org/10.1038/s41409-020-01037-4
Springer Nature Limited

Correction: GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma

Author information

Authors and Affiliations

Consortia

The ATL Working Group of the Japanese Society for Hematopoietic Cell Transplantation

Corresponding author

Rights and permissions

About this article

Cite this article

Share this article

Search

Navigation